Holly E. Anderson

805 total citations · 1 hit paper
13 papers, 566 citations indexed

About

Holly E. Anderson is a scholar working on Immunology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Holly E. Anderson has authored 13 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Holly E. Anderson's work include Complement system in diseases (5 papers), Platelet Disorders and Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). Holly E. Anderson is often cited by papers focused on Complement system in diseases (5 papers), Platelet Disorders and Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). Holly E. Anderson collaborates with scholars based in United Kingdom, United States and France. Holly E. Anderson's co-authors include David Kavanagh, Eric H. Souied, Jacqueline I. Goldstein, Elizabeth C. Miller, Sivakumar Gowrisankar, Yi Yu, John P. Atkinson, Soumya Raychaudhuri, Mark J. Daly and Nicholas Katsanis and has published in prestigious journals such as Nature Genetics, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Holly E. Anderson

13 papers receiving 563 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human uterine natural killer cells regulate differentiation of extravillous trophoblast early in pregnancy

2024 39 citations Qian Li, Andrew Sharkey et al. Cell stem cell profile →

Peers

Holly E. Anderson

IMMUN

OPHTH

HEMAT

RNMI

Jeong-Hyeon Sohn United States

Zoe Chen United States

Sheila Pinto Spain

Lindsay Keir United Kingdom

Norikuni Kawanaka Japan

Kazuhiro Mochizuki Japan

Maryam Tahvildari United States

Anne Katrin Lampe United Kingdom

Dao X. Nguyen United Kingdom

Jeong-Hyeon Sohn United States

Holly E. Anderson

311 ×1.2

IMMUN

477 ×2.3

OPHTH

184 ×1.0

43 ×0.4

HEMAT

177 ×1.8

RNMI

Citations per year, relative to Holly E. Anderson Holly E. Anderson (= 1×) peers Jeong-Hyeon Sohn

Countries citing papers authored by Holly E. Anderson

Since Specialization

Citations

This map shows the geographic impact of Holly E. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly E. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly E. Anderson more than expected).

Fields of papers citing papers by Holly E. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly E. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly E. Anderson. The network helps show where Holly E. Anderson may publish in the future.

Co-authorship network of co-authors of Holly E. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Holly E. Anderson. A scholar is included among the top collaborators of Holly E. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly E. Anderson. Holly E. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Varma, Ashok K., Claire Simon, Holly E. Anderson, et al.. (2025). Ectopic expression of DNMT3L in human trophoblast stem cells restores features of the placental methylome. Cell stem cell. 32(2). 276–292.e9. 3 indexed citations

Anderson, Holly E., et al.. (2025). The Rac1 homolog CED-10 is a component of the MES-1/SRC-1 pathway for asymmetric division of the Caenorhabditis elegans EMS blastomere. Genetics. 229(4). 1 indexed citations

Li, Qian, Andrew Sharkey, Megan A. Sheridan, et al.. (2024). Human uterine natural killer cells regulate differentiation of extravillous trophoblast early in pregnancy. Cell stem cell. 31(2). 181–195.e9. 39 indexed citations breakdown →

Lewis, Amy, Holly E. Anderson, Tamara Sipka, et al.. (2023). An arginase 2 promoter transgenic line illuminates immune cell polarisation in zebrafish. Disease Models & Mechanisms. 16(6). 5 indexed citations

Wong, Edwin, Thomas M Hallam, Vicky Brocklebank, et al.. (2021). Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD. Frontiers in Immunology. 11. 602284–602284. 14 indexed citations

Challis, Rachel, Edwin Wong, Holly E. Anderson, et al.. (2015). A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology. 27(6). 1617–1624. 30 indexed citations

Wong, Edwin, Holly E. Anderson, Andrew P. Herbert, et al.. (2014). Characterization of a Factor H Mutation That Perturbs the Alternative Pathway of Complement in a Family with Membranoproliferative GN. Journal of the American Society of Nephrology. 25(11). 2425–2433. 31 indexed citations

Seddon, Johanna M., Yi Yu, Elizabeth C. Miller, et al.. (2013). Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nature Genetics. 45(11). 1366–1370. 262 indexed citations

Kavanagh, David, Isabel Y. Pappworth, Holly E. Anderson, et al.. (2012). Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome. Clinical Journal of the American Society of Nephrology. 7(3). 417–426. 49 indexed citations

10.

Anderson, Holly E., et al.. (2010). Silencing Mediated by the Schizosaccharomyces pombe HIRA Complex Is Dependent upon the Hpc2-Like Protein, Hip4. PLoS ONE. 5(10). e13488–e13488. 25 indexed citations

11.

Anderson, Holly E., et al.. (2009). The Fission Yeast HIRA Histone Chaperone Is Required for Promoter Silencing and the Suppression of Cryptic Antisense Transcripts. Molecular and Cellular Biology. 29(18). 5158–5167. 49 indexed citations

12.

Hogarth, Linda, Christopher P.F. Redfern, Jens M. Teodoridis, et al.. (2008). The effect of thiopurine drugs on DNA methylation in relation to TPMT expression. Biochemical Pharmacology. 76(8). 1024–1035. 27 indexed citations

13.

McMillan, Robert, Ron D. Bowditch, P Tani, Holly E. Anderson, & Scott H. Goodnight. (1996). A non‐thrombocytopenic bleeding disorder due to an IgG4‐kappa anti‐GPIIb/IIIa autoantibody. British Journal of Haematology. 95(4). 747–749. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact